XYWAV for Narcolepsy

I WON’T TAKE NARCOLEPSY LYING DOWN

92% less sodium than sodium oxybate

XYWAV oral solution, 0.5 g/mL total salts (equivalent to 0.413 g/mL of oxybate) is a prescription medicine used to treat the following symptoms in people 7 years of age or older with narcolepsy:

Sudden onset of weak or paralyzed muscles (cataplexy)

Excessive daytime sleepiness (EDS)

XYWAV is available only through a restricted program under a Risk Evaluation and Mitigation Strategy (REMS) called the XYWAV and XYREM REMS.

The FDA has released important findings about XYWAV

XYWAV is clinically superior* to XYREM^® (sodium oxybate) oral solution by means of greater safety because XYWAV contains significantly less sodium than XYREM

The differences in sodium content between XYWAV and XYREM at recommended doses will be clinically meaningful in reducing cardiovascular diseases for many people with narcolepsy who suffer from EDS and/or cataplexy

*The decision of the FDA Office of Orphan Product Development (OOPD) is based on findings that XYWAV provides a greatly reduced chronic sodium burden compared to XYREM. There are no head-to-head data for XYWAV and XYREM.

The XYWAV Coupon Program

If you are eligible, you MAY PAY AS LITTLE AS $5 PER PRESCRIPTION*^†^‡

*Subject to a maximum monthly benefit.

^†You must be a resident of the US, Puerto Rico, or other US territory.

^‡You must be eligible, commercially insured, and enrolled in the XYWAV and XYREM REMS.

Learn about financial assistance for eligible people taking XYWAV

SHOW ME HOW TO SAVE

can educate and inspire

Standup Champions are people who take XYWAV and want to share their experiences to help and inspire others. Watch Oscar's videos to follow him through a typical day and learn how he fits XYWAV treatment into his life, and see others' stories too!

Go to standup champions

Why you should talk to your doctor about XYWAV today

The efficacy and safety of XYWAV for the treatment of cataplexy and excessive daytime sleepiness in adult patients with narcolepsy were demonstrated in a clinical trial.

Like XYREM, XYWAV contains oxybate.

XYWAV has 92% less sodium than XYREM in each nightly dose.

XYWAV is a lower-sodium oxybate treatment than XYREM^®(sodium oxybate) oral solution and is also approved to treat cataplexy or excessive daytime sleepiness in people with narcolepsy.

Learn more

Important Safety Information

WARNING: Taking XYWAV with other central nervous system (CNS) depressants such as medicines used to make you or your child fall asleep, including opioid analgesics, benzodiazepines, sedating antidepressants, antipsychotics, sedating anti-epileptic medicines, general anesthetics, muscle relaxants, alcohol, or street drugs, may cause serious medical problems, including trouble breathing (respiratory depression), low blood pressure (hypotension), changes in alertness (drowsiness), fainting (syncope), and death.

The active ingredient of XYWAV is a form of gamma-hydroxybutyrate (GHB). Abuse or misuse of illegal GHB alone or with other drugs that cause changes in alertness (or consciousness) has caused serious side effects. These effects include seizures, trouble breathing (respiratory depression), changes in alertness (drowsiness), coma, and death. Call your doctor right away if you or your child has any of these serious side effects.

Because of these risks, you have to go through the XYWAV and XYREM REMS to have your or your child's prescription for XYWAV filled.

Do not take XYWAV if you take or your child takes other sleep medicines or sedatives (medicines that cause sleepiness), drinks alcohol, or has a rare problem called succinic semialdehyde dehydrogenase deficiency.

Keep XYWAV in a safe place to prevent abuse and misuse. Selling or giving away XYWAV may harm others, and is against the law. Tell your doctor if you have ever abused or been dependent on alcohol, prescription medicines, or street drugs.

Anyone who takes XYWAV should not do anything that requires them to be fully awake or is dangerous, including driving a car, using heavy machinery, or flying an airplane, for at least 6 hours after taking XYWAV. Those activities should not be done until you know how XYWAV affects you or your child.

XYWAV can cause serious side effects, including the following:

Breathing problems, including slower breathing, trouble breathing, and/or short periods of not breathing while sleeping (sleep apnea). People who already have breathing or lung problems have a higher chance of having breathing problems when they use XYWAV.

Mental health problems, including confusion, seeing or hearing things that are not real (hallucinations), unusual or disturbing thoughts (abnormal thinking), feeling anxious or upset, depression, thoughts of killing yourself or trying to kill yourself, increased tiredness, feelings of guilt or worthlessness, or difficulty concentrating. Tell your doctor if you or your child have or had depression or have tried to harm yourself or themselves. Call your doctor right away if you have or your child has symptoms of mental health problems or a change in weight or appetite.

Sleepwalking. XYWAV can cause sleepwalking, which can cause injuries. Call your doctor if this occurs.

The most common side effects of XYWAV in adults include nausea, headache, dizziness, anxiety, insomnia, decreased appetite, excessive sweating (hyperhidrosis), vomiting, diarrhea, dry mouth, parasomnia (a sleep disorder that can include abnormal dreams, abnormal rapid eye movement (REM) sleep, sleep paralysis, sleep talking, sleep terror, sleep-related eating disorder, sleepwalking, and other abnormal sleep-related events), somnolence, fatigue, and tremor.

The most common side effects of XYREM (which also contains oxybate like XYWAV) in children include nausea, bedwetting, vomiting, headache, weight decrease, decreased appetite, dizziness, and sleepwalking.

XYWAV can cause physical dependence and craving for the medicine when it is not taken as directed. These are not all the possible side effects of XYWAV.

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch, or call 1-800-FDA-1088.